tiprankstipranks
Trending News
More News >
Science Group PLC (GB:SAG)
LSE:SAG
UK Market

Science (SAG) AI Stock Analysis

Compare
5 Followers

Top Page

GB:SAG

Science

(LSE:SAG)

Select Model
Select Model
Select Model
Outperform 77 (OpenAI - 5.2)
Rating:77Outperform
Price Target:
621.00p
â–²(13.42% Upside)
Science Group's strong financial performance and strategic corporate actions, such as share buybacks, are the most significant factors contributing to its score. The stock's undervaluation and solid dividend yield further enhance its attractiveness. However, technical indicators suggest caution in the short term.
Positive Factors
Revenue Growth
Consistent revenue growth indicates expanding market reach and product adoption, supporting long-term business sustainability.
Cash Flow Generation
Strong cash flow generation provides financial flexibility, enabling reinvestment in R&D and strategic initiatives for sustained growth.
Profit Margins
Healthy profit margins reflect effective cost management and operational efficiency, contributing to long-term profitability.
Negative Factors
Liabilities Monitoring
Rising liabilities could strain financial resources, potentially impacting future investment capacity and financial health.
Debt Management
Effective debt management is crucial to ensure financial stability and avoid potential liquidity issues in the long term.
Leverage Position
While leverage is currently conservative, any increase could impact financial flexibility and risk profile.

Science (SAG) vs. iShares MSCI United Kingdom ETF (EWC)

Science Business Overview & Revenue Model

Company DescriptionScience Group plc, together with its subsidiaries, provides science and technology-based consultancy services in the United Kingdom, North America, Europe, and internationally. The company operates through R&D Consultancy; Regulatory & Compliance; and Frontier Smart Technologies divisions. It offers product and technology development, scientific and regulatory advice, and registration and compliance services to medical, food and beverage, consumer, industrial, chemical, and energy sectors. The company also provides property services. In addition, it manufactures and sells chips, and modules, which are incorporated into digital radios. The company was formerly known as Sagentia Group plc and changed its name to Science Group plc in July 2015. Science Group plc was incorporated in 2008 and is headquartered in Cambridge, the United Kingdom.
How the Company Makes MoneyScience (SAG) generates revenue through multiple channels, primarily by offering a diverse range of products and services tailored to the needs of research institutions, laboratories, and industrial clients. Key revenue streams include the sale of proprietary scientific equipment, software solutions for laboratory management, and consultancy services in research methodologies. Additionally, the company has established strategic partnerships with academic institutions and industry leaders, allowing it to leverage collaborative research funding and joint ventures. These partnerships not only enhance its product offerings but also expand its market reach, contributing to consistent revenue growth. Licensing agreements for patented technologies and ongoing maintenance contracts for its software solutions further bolster the company's earnings.

Science Financial Statement Overview

Summary
Science demonstrates a robust financial performance with strong revenue and profit growth, efficient cost management, and solid cash flow generation. The balance sheet reflects a stable financial position with conservative leverage. Continued monitoring of liabilities is advisable to maintain financial health.
Income Statement
The company shows strong revenue growth with a significant increase from 2019 to 2024. Gross profit margins have remained healthy, indicating efficient cost management. The net profit margin has improved substantially, reflecting enhanced profitability. The EBIT and EBITDA margins are robust, demonstrating effective operational performance.
Balance Sheet
The balance sheet is solid with a favorable debt-to-equity ratio, indicating a conservative leverage position. The equity ratio is strong, reflecting a stable financial structure. Return on equity has improved, showcasing effective use of equity capital. However, the increase in total liabilities warrants monitoring.
Cash Flow
The company exhibits strong cash flow generation with consistent free cash flow growth. The operating cash flow to net income ratio is healthy, indicating efficient cash conversion. The free cash flow to net income ratio is also strong, highlighting effective cash management strategies.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue114.15M110.67M113.34M86.30M81.22M73.66M
Gross Profit45.27M45.18M46.25M38.35M35.36M29.80M
EBITDA20.90M21.13M15.15M16.64M16.00M11.62M
Net Income30.79M12.02M5.52M10.55M9.56M7.04M
Balance Sheet
Total Assets170.34M141.09M132.45M127.28M115.94M92.05M
Cash, Cash Equivalents and Short-Term Investments84.42M41.45M32.83M46.51M37.19M29.07M
Total Debt14.90M15.49M16.90M16.02M16.88M18.79M
Total Liabilities62.97M57.09M54.46M49.08M49.64M50.66M
Stockholders Equity107.36M84.00M77.99M78.20M66.29M41.39M
Cash Flow
Free Cash Flow30.53M18.48M7.83M15.18M9.15M17.54M
Operating Cash Flow30.57M18.48M7.91M15.27M14.01M17.69M
Investing Cash Flow24.39M723.00K-12.78M-34.00K-19.08M-134.00K
Financing Cash Flow-11.09M-10.72M-8.49M-6.46M13.08M-3.53M

Science Technical Analysis

Technical Analysis Sentiment
Positive
Last Price547.50
Price Trends
50DMA
545.45
Positive
100DMA
550.95
Positive
200DMA
520.72
Positive
Market Momentum
MACD
1.11
Negative
RSI
79.90
Negative
STOCH
37.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SAG, the sentiment is Positive. The current price of 547.5 is below the 20-day moving average (MA) of 547.88, above the 50-day MA of 545.45, and above the 200-day MA of 520.72, indicating a bullish trend. The MACD of 1.11 indicates Negative momentum. The RSI at 79.90 is Negative, neither overbought nor oversold. The STOCH value of 37.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:SAG.

Science Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
£235.92M8.0632.09%1.46%2.90%419.40%
75
Outperform
£409.50M21.9715.29%2.13%32.67%-1.61%
69
Neutral
£186.68M18.8412.60%3.91%8.31%305.88%
66
Neutral
£220.89M34.456.18%1.83%23.37%4.75%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
56
Neutral
£141.39M31.025.86%8.80%6.04%-24.55%
52
Neutral
£24.32M38.971.56%―-4.67%590.48%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:SAG
Science
555.00
98.00
21.44%
GB:BEG
Begbies Traynor
117.00
23.63
25.31%
GB:GTLY
Gateley (Holdings)
103.00
-17.22
-14.32%
GB:MANO
Manolete Partners Plc
56.50
-17.50
-23.65%
GB:ELIX
Elixirr International Plc
860.00
138.47
19.19%
GB:FNTL
Fintel PLC
205.00
-56.20
-21.52%

Science Corporate Events

Stock BuybackRegulatory Filings and Compliance
Science Group Continues Share Buyback, Updates Share Capital and Treasury Holdings
Positive
Jan 9, 2026

Science Group plc has continued its share buyback activity, repurchasing 2,000 ordinary shares at an average price of 547.5 pence per share on 8 January 2026 through Panmure Liberum Limited, with all acquired shares to be held in treasury. Following this transaction, the company has 43,089,642 ordinary shares in issue excluding 3,096,232 treasury shares, a capital structure detail that will be used by investors for calculating disclosure thresholds under the FCA’s transparency rules and signals ongoing active capital management by the group.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock Buyback
Science Group Repurchases Shares for Treasury in Ongoing Buyback Activity
Positive
Jan 8, 2026

Science Group plc has executed a share buyback transaction, repurchasing 17,500 of its 1 pence ordinary shares on 7 January 2026 at an average price of 549 pence per share via Panmure Liberum Limited, with all shares to be held in treasury. The buyback, representing about 0.04% of the company’s prior voting rights, leaves 43,091,642 ordinary shares in issue excluding treasury stock and 3,094,232 shares held in treasury, a figure that will now serve as the reference denominator for shareholders’ regulatory disclosure calculations, and signals continued capital management activity that can support earnings per share and shareholder value over time.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares, Adjusts Free-Float and Treasury Holdings
Neutral
Jan 7, 2026

Science Group plc has repurchased 17,500 of its own 1 pence ordinary shares at an average price of 547.5 pence per share in a transaction executed on 6 January 2026 through Panmure Liberum Limited. The buyback represents 0.04% of the company’s prior voting rights, and the shares will be held in treasury, leaving 43,109,142 ordinary shares in issue excluding treasury stock and 3,076,732 shares now held in treasury, a figure shareholders can use to assess disclosure thresholds under UK transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back 17,000 Shares for Treasury, Updates Capital Base
Neutral
Jan 6, 2026

Science Group plc has continued its share buyback activity, purchasing 17,000 ordinary shares of 1 pence each on 5 January 2026 at an average price of 548 pence per share through Panmure Liberum Limited. The shares, representing approximately 0.04% of the company’s prior voting rights, will be held in treasury, bringing the total number of ordinary shares in issue excluding treasury shares to 43,126,642 and treasury holdings to 3,059,232 shares; this updated capital structure figure will serve as the new denominator for investors assessing disclosure thresholds under FCA transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Regulatory Filings and Compliance
Science Group Updates Total Voting Rights and Share Capital
Neutral
Jan 2, 2026

Science Group plc has confirmed that its total issued share capital, excluding treasury shares, comprises 43,143,642 ordinary shares of 1 penny each, while the company also holds 3,042,232 shares in treasury. The updated share capital figure serves as the key denominator for investors when calculating whether their holdings trigger disclosure obligations under the UK Financial Conduct Authority’s Disclosure and Transparency Rules, providing clarity for shareholders and the market on reporting thresholds for changes in ownership stakes.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Buys Back Shares for Treasury, Adjusting Free Float and Disclosure Base
Neutral
Dec 19, 2025

Science Group plc has repurchased 9,000 of its 1 pence ordinary shares at an average price of 547.5 pence per share, representing about 0.02% of its prior voting share capital, through broker Panmure Liberum Limited. The shares bought back will be held in treasury, leaving 43,143,642 ordinary shares in issue excluding treasury stock and 3,042,232 shares held in treasury, a structure that may influence future capital management flexibility and is relevant for shareholders’ regulatory disclosure calculations under FCA transparency rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Science Group Executes Share Buyback Program
Neutral
Dec 18, 2025

Science Group PLC announced the repurchase of 15,000 of its ordinary shares at an average price of 546.5 pence per share, constituting approximately 0.03% of the voting rights prior to the transaction. This purchase, conducted through Panmure Liberum Limited, reflects the company’s ongoing buyback program, with the repurchased shares to be held in treasury. Following this transaction, the company has 43,152,642 ordinary shares in issue, not including treasury shares. The move aligns with regulatory requirements and provides updated information for shareholders concerning their disclosure obligations.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Dec 17, 2025

Science Group PLC announced the repurchase of 15,000 of its ordinary shares at a price of 546.75 pence per share, representing 0.03% of the voting rights. These shares will be held in treasury, adjusting the total number of shares in issue to 43,167,642. This transaction is part of the company’s ongoing buyback program, potentially impacting shareholder calculations under FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock Buyback
Science Group plc Executes Share Buyback
Neutral
Dec 16, 2025

Science Group plc announced the repurchase of 15,000 of its ordinary shares at an average price of 545.5 pence per share, representing 0.03% of the voting rights. These shares will be held in treasury, impacting the total number of shares in issue, which now stands at 43,182,642. This buyback is part of the company’s ongoing strategy to manage its capital structure and may influence shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Dec 11, 2025

Science Group PLC has announced the repurchase of 5,000 of its ordinary shares at an average price of 545.5 pence per share, representing 0.01% of the voting rights. The shares will be held in treasury, and the total number of shares in issue, excluding treasury shares, is now 43,397,642. This transaction is part of the company’s ongoing buyback program, which may impact shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Announces Share Buyback
Neutral
Dec 8, 2025

Science Group PLC has announced a share buyback, purchasing 17,500 of its ordinary shares at an average price of 546.75 pence per share. This transaction represents a small fraction of the company’s total voting rights and is part of its ongoing efforts to manage its capital structure effectively. The purchased shares will be held in treasury, and the updated number of shares in issue will serve as a reference for shareholders under regulatory guidelines.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £621.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Dec 4, 2025

Science Group PLC announced the repurchase of 15,000 ordinary shares at an average price of 544.5 pence per share, representing 0.03% of the voting rights. The shares will be held in treasury, and the total number of ordinary shares in issue, excluding treasury shares, is now 43,420,142. This transaction is part of the company’s buyback program and may affect shareholder calculations under the FCA’s rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group Announces Share Buyback
Neutral
Dec 2, 2025

Science Group plc, a company listed on the AIM market, has announced the repurchase of 17,500 of its ordinary shares at an average price of 537.875 pence per share. This transaction represents 0.04% of the voting rights of the total ordinary shares prior to the purchase, and the shares will be held in treasury. This move is part of the company’s buyback program, which could impact shareholder calculations regarding their interests in the company under regulatory guidelines.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Regulatory Filings and Compliance
Science Group PLC Announces Total Voting Rights
Neutral
Dec 1, 2025

Science Group PLC announced its total issued share capital, excluding treasury shares, consists of 43,452,642 shares of 1 penny each. The company holds 2,733,232 shares in treasury, and this figure is relevant for shareholders to determine their interest in the company under the FCA’s Disclosure and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback Program
Neutral
Nov 28, 2025

Science Group PLC, a company listed on the AIM market, has executed a share buyback program, purchasing 10,000 of its ordinary shares at a consistent price of 536 pence per share. This transaction represents a minor portion of the company’s total voting rights and the shares will be held in treasury, impacting the total number of shares available for shareholder calculations under regulatory guidelines.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Announces Share Buyback
Neutral
Nov 26, 2025

Science Group PLC has repurchased 17,500 of its ordinary shares at an average price of 538.75 pence per share, representing 0.04% of the voting rights. This transaction, executed through Panmure Liberum Limited, aims to manage the company’s capital structure by holding these shares in treasury, impacting shareholder calculations under FCA rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock Buyback
Science Group PLC Announces Share Buyback
Neutral
Nov 25, 2025

Science Group PLC announced the repurchase of 17,500 of its ordinary shares at a price of 539 pence each, representing 0.04% of the total voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s strategy to manage its share capital, with the purchased shares held in treasury. The total number of shares in issue, excluding treasury shares, is now 43,480,142, which shareholders can use for interest notifications under FCA rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group Announces Share Buyback
Neutral
Nov 24, 2025

Science Group plc, a company listed on the AIM market, announced the repurchase of 17,500 of its ordinary shares at a price of 540 pence per share. This transaction represents 0.04% of the voting rights of the total ordinary shares in issue prior to the purchase. The repurchased shares will be held in treasury, and the total number of ordinary shares in issue, excluding treasury shares, is now 43,497,642. This buyback may have implications for shareholders in terms of their interest notifications under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback Program
Neutral
Nov 21, 2025

Science Group PLC announced the repurchase of 17,500 of its ordinary shares at an average price of 542.375 pence per share, representing 0.04% of the voting rights. The shares will be held in treasury, and the total number of ordinary shares in issue, excluding treasury shares, is now 43,515,142. This transaction is part of the company’s ongoing buyback program, potentially impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group Repurchases 540,000 Shares to Hold in Treasury
Neutral
Nov 20, 2025

Science Group plc, a company listed on the AIM market, has repurchased 540,000 of its ordinary shares at a price of 540 pence each, representing 1.23% of the voting rights of the total ordinary shares prior to the purchase. These shares will be held in treasury, adjusting the total number of ordinary shares in issue to 43,532,642, which shareholders can use as a reference for their interest notifications according to FCA rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Private Placements and FinancingRegulatory Filings and Compliance
Science Group Issues Treasury Shares to Settle Share Options
Neutral
Nov 17, 2025

Science Group plc announced the issuance of 5,000 treasury shares at an average price of 1 pence per share to settle the exercise of share options. Following this issuance, the total number of ordinary shares in issue, excluding treasury shares, is 44,072,642. This figure is significant for shareholders as it serves as the denominator for calculating their interest in the company under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Nov 17, 2025

Science Group PLC has repurchased 17,500 of its ordinary shares at a price of 543.5 pence each, representing 0.04% of its total voting rights. This buyback, conducted through Panmure Liberum Limited, will see the shares held in treasury, adjusting the total number of shares in issue to 44,067,642. This move may impact shareholder notifications under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock Buyback
Science Group PLC Announces Share Buyback
Neutral
Nov 5, 2025

Science Group PLC has announced a share buyback, purchasing 17,500 of its ordinary shares at an average price of 552 pence per share. This transaction represents 0.04% of the company’s voting rights and is part of a strategic move to hold shares in treasury, potentially impacting shareholder calculations under FCA rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock Buyback
Science Group PLC Executes Share Buyback to Enhance Equity Structure
Neutral
Nov 4, 2025

Science Group PLC announced the repurchase of 17,500 of its ordinary shares at a consistent price of 550.875 pence per share, representing 0.04% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s buyback program and results in a total of 44,102,642 ordinary shares in issue, excluding treasury shares. The move is likely aimed at consolidating the company’s share capital and potentially enhancing shareholder value, reflecting a strategic decision to manage its equity structure.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Regulatory Filings and Compliance
Science Group PLC Announces Total Voting Rights
Neutral
Nov 3, 2025

Science Group PLC has announced its total issued share capital, excluding treasury shares, consists of 44,120,142 shares of 1 penny each, with 2,065,732 shares held in treasury. This information is crucial for shareholders to determine their interest in the company according to the FCA’s Disclosure and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback to Optimize Capital Structure
Positive
Oct 31, 2025

Science Group PLC has announced the repurchase of 8,000 of its ordinary shares at a price of 551.75 pence each, representing 0.02% of the voting rights. This transaction is part of the company’s ongoing share buyback program, aimed at optimizing its capital structure and potentially enhancing shareholder value.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback Program
Neutral
Oct 30, 2025

Science Group PLC announced the repurchase of 17,500 of its ordinary shares at a consistent price of 551.25 pence per share, representing 0.04% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s buyback program, with the repurchased shares held in treasury, impacting the total number of shares available for shareholder calculations.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Private Placements and FinancingRegulatory Filings and Compliance
Science Group Issues Treasury Shares to Settle Options
Neutral
Oct 29, 2025

Science Group plc has issued 15,000 treasury shares at an average price of 1 pence per share to settle share options. This increases the total number of ordinary shares in issue to 44,145,642, excluding treasury shares, and provides shareholders with a new denominator for calculating their interest in the company under FCA rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock Buyback
Science Group plc Executes Share Buyback Strategy
Neutral
Oct 28, 2025

Science Group plc has announced the repurchase of 17,500 of its ordinary shares at a price of 551.25 pence each, representing 0.04% of the voting rights of the total shares in issue prior to the purchase. This transaction, executed through Panmure Liberum Limited, reflects the company’s ongoing strategy to manage its share capital effectively, potentially impacting shareholder value and market perception.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £622.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Oct 24, 2025

Science Group PLC, a company listed on the AIM market, has repurchased 8,000 of its ordinary shares at an average price of 551.5 pence per share. This transaction represents 0.02% of the voting rights attributable to the total ordinary shares in issue prior to the purchase, and the shares will be held in treasury. This move allows shareholders to use the updated figure of 44,148,142 ordinary shares in issue, excluding treasury shares, for any necessary calculations under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £622.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Regulatory Filings and Compliance
Science Group Issues Treasury Shares Amid Share Option Exercise
Neutral
Oct 24, 2025

Science Group plc announced the issuance of 5,000 treasury shares at an average price of 1 pence per share to settle the exercise of share options. Following this issuance, the total number of ordinary shares in issue, excluding treasury shares, is 44,156,142, with 2,029,732 shares held in treasury. This update is relevant for shareholders to determine their interest in the company under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £622.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback Program
Neutral
Oct 23, 2025

Science Group PLC announced the repurchase of 17,500 of its ordinary shares at a price of 551.25 pence per share, representing 0.04% of the voting rights. This transaction is part of a buyback program executed through Panmure Liberum Limited, with the shares being held in treasury. The move adjusts the total number of ordinary shares in issue to 44,151,142, excluding treasury shares, which may impact shareholder calculations under FCA rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £611.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Oct 21, 2025

Science Group PLC has repurchased 17,500 of its ordinary shares at an average price of 551.5 pence per share, representing 0.04% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s ongoing share buyback program, which may impact shareholder calculations under the FCA’s rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £611.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock Buyback
Science Group PLC Announces Share Buyback
Neutral
Oct 20, 2025

Science Group PLC announced the repurchase of 18,000 of its ordinary shares at an average price of 551.25 pence per share, representing 0.04% of the voting rights. These shares will be held in treasury, and the total number of shares in issue, excluding treasury shares, is now 44,186,142. This buyback is part of the company’s ongoing strategy to manage its capital structure effectively, potentially impacting shareholder value and market perception.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £611.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback Program
Neutral
Oct 17, 2025

Science Group PLC announced the repurchase of 12,700 of its ordinary shares at a price of 551.75 pence per share, representing 0.03% of the voting rights. This transaction is part of the company’s buyback program, with the acquired shares held in treasury, impacting the total number of shares in issue and potentially affecting shareholder notifications under FCA rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £611.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Announces Share Buyback
Neutral
Oct 16, 2025

Science Group PLC has announced the repurchase of 15,000 of its ordinary shares at an average price of 552.4 pence per share, representing 0.03% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s share buyback program, with the purchased shares held in treasury. The total number of ordinary shares in issue now stands at 44,216,842, excluding treasury shares. This move may impact shareholders’ calculations regarding their interests in the company, as per the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £611.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback
Neutral
Oct 15, 2025

Science Group PLC announced the repurchase of 18,000 of its ordinary shares at an average price of 552.5 pence per share, which represents 0.04% of the voting rights. The shares will be held in treasury, and this transaction is part of the company’s ongoing share buyback program, potentially impacting shareholder calculations under FCA rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £624.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock Buyback
Science Group PLC Executes Share Buyback
Neutral
Oct 14, 2025

Science Group PLC has repurchased 17,500 of its ordinary shares at an average price of 553.97 pence per share, with the transactions executed through Panmure Liberum Limited. This buyback represents 0.04% of the voting rights and is part of the company’s strategy to manage its share capital, potentially impacting shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Business Operations and StrategyStock BuybackDividendsFinancial Disclosures
Science Group Reports Strong Performance Amid Market Volatility
Positive
Oct 13, 2025

Science Group has announced a trading update for the nine months ending 30 September 2025, reporting a record Adjusted Operating Profit despite challenging market conditions. The company achieved a significant pre-tax gain from a strategic investment in the first half of the year, contributing to a strong cash position. With a recovery in R&D services led by the Medical sector, Science Group remains on track to meet or exceed its annual performance expectations, continuing to return value to shareholders through dividends and share buy-backs.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Stock Buyback
Science Group PLC Executes Share Buyback Program
Neutral
Oct 13, 2025

Science Group PLC has repurchased 10,000 of its ordinary shares at an average price of 552.75 pence per share, representing 0.02% of the voting rights. This transaction, executed through Panmure Liberum Limited, is part of the company’s share buyback program and will see the shares held in treasury, impacting the total number of shares available for shareholder calculations under regulatory rules.

The most recent analyst rating on (GB:SAG) stock is a Buy with a £616.00 price target. To see the full list of analyst forecasts on Science stock, see the GB:SAG Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025